Drug Trial Radar · NCT06736938
Balanced Analgosedation in Bronchoscopy: Propofol/Pethidine Versus Midazolam/Pethidine
Last checked: Nov 20, 2026Latest source record: Dec 17, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
530
Planned (sponsor's estimate)
Start
Apr 1, 2025
Primary completion
Apr 1, 2027
Study completion Apr 1, 2027
Sponsor
- Lead sponsor
- Fondazione Andrea Cesalpino Arezzo ONLUSAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Azienda USL Toscana Sud Est; Ospedale San Donato, Arezzo
- First posted
- Dec 17, 2024
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Other
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this clinical trial is to compare the safety and efficacy of two pharmacological sedation regimens during bronchoscopy procedures in adult patients who require elective bronchoscopy. The main questions it aims to answer are: * Is propofol/pethidine analgesia administered by a pulmonologist as effective and safe as midazolam/pethidine in achieving adequate sedation during bronchoscopy, particularly in terms of desaturation rate? * Does the choice of sedative (midazolam vs. propofol) influence the occurrence of adverse events or need for escalated care?
Conditions
- Sedation During Bronchoscopy
Interventions
Propofol 1%Drug
Propofol 1% is infused intravenously, initially at a bolus dose of 0.5 mg/kg followed by a maintenance dose in a continuous infusion of 0.5-1.0 mg/kg/hour.
MidazolamDrug
Midazolam is administered intravenously at an initial dose of 2 mg, as a bolus, followed by aliquots of 0.5 mg or 1 mg.
PethidineDrug
Pethidine (100 mg/2 ml) is administered intravenously at a dosage of 0.5 mg/kg.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Desaturation IndexTime frame: Trough study completion, an average of 2 years
Locations
1 site in 1 country. Site status is shown where the registry gives one.
San Donato Hospital
Arezzo, Italy
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.